XBIOTECH INC. Construction in Progress Expenditures Incurred but Not yet Paid
XBIOTECH INC. (XBIT) reported Construction in Progress Expenditures Incurred but Not yet Paid of $439.00 thousand for the 12-month period ending 2016-12-31, per its 10-K/A filed 2019-03-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid · last filed 2019-03-15
- XBIOTECH INC. construction in progress expenditures incurred but not yet paid for the quarter ending 2016-12-31 was -$828.00K, a 316.75% decline year-over-year.
- XBIOTECH INC. construction in progress expenditures incurred but not yet paid for the quarter ending 2016-09-30 was -$283.00K.
- XBIOTECH INC. construction in progress expenditures incurred but not yet paid for the quarter ending 2016-06-30 was -$413.00K.
- XBIOTECH INC. construction in progress expenditures incurred but not yet paid for the quarter ending 2016-03-31 was $1.96M.
- XBIOTECH INC. construction in progress expenditures incurred but not yet paid for fiscal 2016 was $439.00K, a 69.00% decline from fiscal 2015.
- XBIOTECH INC. construction in progress expenditures incurred but not yet paid for fiscal 2015 was $1.42M, a 532.14% increase from fiscal 2014.
- XBIOTECH INC. construction in progress expenditures incurred but not yet paid for fiscal 2014 was $224.00K.
| Period end | Construction in Progress Expenditures Incurred but Not yet Paid 3 month | Construction in Progress Expenditures Incurred but Not yet Paid 3 month as first filed | Construction in Progress Expenditures Incurred but Not yet Paid 6 month | Construction in Progress Expenditures Incurred but Not yet Paid 6 month as first filed | Construction in Progress Expenditures Incurred but Not yet Paid 9 month | Construction in Progress Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|---|---|
| 2016-12-31 | -$828.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-15 | -$1.11M derived: sum of 2 quarters · filed 2019-03-15 | -$1.52M derived: sum of 3 quarters · filed 2019-03-15 | $439.00K 10-K/A · filed 2019-03-15 | ||
| 2016-09-30 | -$283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$696.00K derived: sum of 2 quarters · filed 2017-11-09 | $1.27M 10-Q · filed 2017-11-09 | $1.65M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-06-30 | -$413.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.55M 10-Q · filed 2017-08-08 | $1.55B 10-Q · filed 2016-08-12 | $1.93M derived: sum of 3 quarters · filed 2018-03-16 | ||
| 2016-03-31 | $1.96M 10-Q · filed 2017-05-10 | $1.96B 10-Q · filed 2016-05-13 | $2.35M derived: sum of 2 quarters · filed 2018-03-16 | |||
| 2015-12-31 | $382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $1.42M 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $1.03M 10-Q · filed 2016-11-14 | |||||
| 2014-12-31 | $224.00K 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |